Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Sell
2,057
-101
-5% -$34.6K 0.48% 49
2026
Q1
$759K Buy
2,158
+25
+1% +$8.91K 0.53% 50
2025
Q4
$698K Sell
2,133
-44
-2% -$14K 0.5% 50
2025
Q3
$614K Buy
2,177
+5
+0.2% +$1.45K 0.44% 58
2025
Q2
$606K Buy
2,172
+94
+5% +$26.6K 0.46% 57
2025
Q1
$647K Sell
2,078
-27
-1% -$7.97K 0.56% 44
2024
Q4
$549K Buy
+2,105
New +$625K 0.47% 52
2022
Q4
$516K Buy
+1,965
New +$527K 0.59% 38

Other funds holding AMGN

Ipsen Advisor Group's AMGN Position: Q2 2026 in Review

Ipsen Advisor Group reduced its Amgen (AMGN) stake by 4.7% in Q2 2026, selling an estimated $34.6K and leaving 2,057 shares worth $745K. The position accounts for 0.48% of the portfolio, ranked #49.

Ipsen Advisor Group first reported a position in AMGN in Q4 2022 and has held it in 8 quarters since. The position peaked at $759K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ipsen Advisor Group held 2,057 shares of Amgen worth $745K as of Q2 2026.
  • Ipsen Advisor Group sold 101 Amgen shares in Q2 2026, an estimated $34.6K.
  • Amgen made up 0.48% of Ipsen Advisor Group's portfolio in Q2 2026, its #49 holding.
  • Ipsen Advisor Group first reported a position in Amgen in Q4 2022 and has held it in 8 quarters since.
  • Ipsen Advisor Group's Amgen position peaked at $759K in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ipsen Advisor Group's 13F filing for Q2 2026, filed 29 Jul 2026.